{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:49:26Z","timestamp":1772610566257,"version":"3.50.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,25]]},"abstract":"<jats:p>Six-monthly blood monitoring is frequently carried out for patients prescribed biological therapy for psoriasis in the UK. Through the analysis of blood results from a cohort of such patients, we demonstrated that a more targeted and coordinated approach to blood monitoring could be implemented, which would subsequently reduce carbon emissions, associated healthcare costs and the impact on patients\u2019 employment.<\/jats:p>","DOI":"10.1093\/ced\/llad340","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T19:11:45Z","timestamp":1696619505000},"page":"181-183","source":"Crossref","is-referenced-by-count":4,"title":["Adopting a personalized approach to blood monitoring in patients with psoriasis prescribed biologic therapy: a retrospective single-centre review of real-world data"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-462X","authenticated-orcid":false,"given":"Amaani B","family":"Hussain","sequence":"first","affiliation":[{"name":"Department of Dermatology, Royal Victoria Infirmary, The\u00a0Newcastle upon Tyne Hospitals Foundation Trust , Newcastle , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Singleton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Victoria Infirmary, The\u00a0Newcastle upon Tyne Hospitals Foundation Trust , Newcastle , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Ball","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Victoria Infirmary, The\u00a0Newcastle upon Tyne Hospitals Foundation Trust , Newcastle , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie C","family":"Weatherhead","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Victoria Infirmary, The\u00a0Newcastle upon Tyne Hospitals Foundation Trust , Newcastle , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick J","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Victoria Infirmary, The\u00a0Newcastle upon Tyne Hospitals Foundation Trust , Newcastle , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J","family":"Hampton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Victoria Infirmary, The\u00a0Newcastle upon Tyne Hospitals Foundation Trust , Newcastle , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"2024012519205630400_llad340-B1","first-page":"307","article-title":"Early intervention and disease memory in psoriasis: a literature review","volume-title":"JEADV Clin Pract","author":"Ben Abdallah","year":"2022"},{"key":"2024012519205630400_llad340-B2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jamadermatol.2022.2909","article-title":"Drug survival associated with effectiveness and safety of treatment with guselkumab, ixekizumab, secukinumab, ustekinumab, and adalimumab in patients with psoriasis","volume":"158","author":"Yiu","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2024012519205630400_llad340-B3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjd.19039","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update","volume":"183","author":"Smith","year":"2020","journal-title":"Br J Dermatol"},{"key":"2024012519205630400_llad340-B4","author":"USA Environmental Protection Agency"},{"key":"2024012519205630400_llad340-B5","author":"Department for Energy Security and Net Zero and Department for Business, Energy and Industrial Strategy"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad340\/53811131\/llad340.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/2\/181\/56420908\/llad340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/2\/181\/56420908\/llad340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T19:21:17Z","timestamp":1706210477000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/2\/181\/7293178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":5,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,10,6]]},"published-print":{"date-parts":[[2024,1,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad340","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,10,6]]}}}